Concepedia

JA Sparano

JS

6

Publications

228

Citations

6

H-Index

1998

Active since

Affiliations

Montefiore Medical Center(Current)

Albert Einstein College of Medicine

Dana-Farber Cancer Institute

Indiana University – Purdue University Indianapolis

WinnMed

JA Sparano is an author at Montefiore Medical Center specializing in breast cancer, oncology, and cancer research.

Top concepts

MedicineOncologyBreast CancerCancer ResearchGynecologyCancer TherapyClinical TrialsMolecular OncologyRadiation OncologyPathology

Publications per year

1998–2019

6

Publications

6

Gemcitabine and radiation therapy for non-small cell lung cancer.

JA Sparano · PubMed · 1998 · 69 citations

Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics.

JA Sparano · PubMed · 1999 · 59 citations

S4-6: A Quantitative Multigene RT-PCR Assay for Predicting Recurrence Risk after Surgical Excision Alone without Irradiation for Ductal Carcinoma In Situ (DCIS): A Prospective Validation Study of the DCIS Score from ECOG E5194.

L.J. Solin, Robert J. Gray, FL Baehner et al. · Cancer Research · 2011 · 36 citations

Surgical Oncology, Cancer Management, Pathology +20

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

NS Kornblum, Judith Manola, Paula Klein et al. · Cancer Research · 2017 · 35 citations

Breast Oncology, Gynecology, Everolimus Arm +21

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

JA Sparano, Anne O’Neill, Katherine Alpaugh et al. · Cancer Research · 2018 · 17 citations

Surgical Oncology, Breast Oncology, Circulating Tumor Cells +24

Rows per page

1–5 of 6